ENYO Pharma vs THRASOS LIMITED
ENYO Pharma
Developing therapeutics for diseases with impaired kidney function
35 employees · est. 2014 · Lyon, France
THRASOS LIMITED
Pioneering targeted therapies to prevent and treat severe organ failure, with a focus on kidney disease
2 employees · est. 2002
THRASOS LIMITED is the older company (2014 vs 2002); ENYO Pharma is the larger of the two.
Side-by-Side Comparison
| Metric | ENYO Pharma | THRASOS LIMITED |
|---|---|---|
| Founded | ||
| Founded | 2014 | 2002 older |
| Headquarters | ||
| Headquarters | Lyon, France | Not tracked yet |
| Employees | ||
| Employees | 35 larger | 2 |
| Industry | ||
| Industry | Biopharma, Biotechnology | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series C | Series D |
| Total Funding | ||
| Total Funding | $103.50M | $56.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 2 |
| Services | ||
| Services | Developing therapeutics for diseases with impaired kidney function | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with impaired kidney function, pharmaceutical companies, research institutions | Not tracked yet |
| Taxonomy | ||
| Taxonomy | BiopharmaceuticalsTherapeuticsChronic Kidney DiseasesRare Kidney DiseasesLiver DiseasesInfectious Diseases +9 | BiopharmaceuticalsTargeted TherapiesOrgan FailureKidney DiseaseAcute Kidney InjuryChronic Kidney Disease +6 |
| Website | ||
| Website | enyopharma.com | thrasos.com |
About ENYO Pharma
ENYO Pharma is a biopharmaceutical company that focuses on developing therapeutics for diseases with impaired kidney function. The company's lead compound, Vonafexor, is currently undergoing Phase 2 trials for Chronic Kidney Diseases (CKD), rare kidney diseases such as Alport syndrome, and liver dis...
About THRASOS LIMITED
THRASOS LIMITED is a bio-therapeutics company focused on pioneering targeted therapies to prevent and treat severe organ failure, with a specific emphasis on kidney disease. Founded in 2002, the company's primary therapeutic program, THR-184, is designed to prevent and treat acute kidney injury (AKI...
Also comparing in this category
Comparing more than these two?
Get ENYO Pharma, THRASOS LIMITED and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does ENYO Pharma compare?
A PDF of ENYO Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Frequently Asked Questions
Compare ENYO Pharma with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at ENYO Pharma on 11 Jun 2025, and THRASOS LIMITED on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
